ORLANDO, Fla. -- Madeline Truman Dang stands a few centimeters shy of 5 feet tall. Although she longs to be taller, the 12-year-old knows that she's lucky to be as tall as she is -- doctors once ...

Two previously unknown stem cell types appear to play a central role in children's height growth, according to a study from ...

The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

Please provide your email address to receive an email when new articles are posted on . Somapacitan-beco is a once-weekly growth hormone injection. New indications expand treatment options for ...

(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...

Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...